News of FDA approval of Synapse Biomedical Inc. FDA approval of TransAeris, its temporary diaphragm pacing device, is circulating in media.
top of page
Search
Recent Posts
See AllNeuRx DPS, the world leading diaphragm pacing device, helping hundreds of pateints move away from mechanical ventilation, has been...
50
Using the same technology of diaphragm pacing as its predecessor, and the flagship of Synapse Biomedical Inc®. NeuRx DPS, FDA has granted...
260
bottom of page
Comments